Generic versions of Pfizer’s Paxlovid to be sold in low-income countries for $25 or less –…
Several generic drugmakers that will produce versions of Pfizer’s PFE.N COVID-19 antiviral treatment Paxlovid have agreed to sell the medicine in low- and middle-income countries for $25 a course or less, the Clinton Health Access…